Colangiocarcinoma intrahepático

1. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?  J Hepatol. 2004;40(3):472-477
2. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.  Hepatology. 2001;33(6):1353-1357
3. Alvaro D, Crocetti E, Ferretti S, Bragazzi MC, Capocaccia R.AISF Cholangiocarcinoma committee.  Descriptive epidemiology of cholangiocarcinoma in Italy.  Dig Liver Dis. 2010;42(7):490-495
4. McGlynn KA, Tarone RE, El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.  Cancer Epidemiol Biomarkers Prev. 2006;15(6):1198-1203
5. Tan JC, Coburn NG, Baxter NN, Kiss A, Law CH. Surgical management of intrahepatic cholangiocarcinoma—a population-based study.  Ann Surg Oncol. 2008;15(2):600-608
6. Weimann A, Varnholt H, Schlitt HJ,  et al.  Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma.  Br J Surg. 2000;87(9):1182-1187
7. Isa T, Kusano T, Shimoji H, Takeshima Y, Muto Y, Furukawa M. Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma.  Am J Surg. 2001;181(6):507-511
8. Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Yamazaki O, Kinoshita H. Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma.  Br J Surg. 2001;88(7):969-974
9. Kawarada Y, Yamagiwa K, Das BC. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma.  Am J Surg. 2002;183(6):679-685
10. Nakagawa T, Kamiyama T, Kurauchi N,  et al.  Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma.  World J Surg. 2005;29(6):728-733
11. Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma.  World J Surg. 2008;32(12):2675-2680
12. Shimada K, Sano T, Nara S,  et al.  Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement.  Surgery. 2009;145(4):411-416
13. Lang H, Sotiropoulos GC, Sgourakis G,  et al.  Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.  J Am Coll Surg. 2009;208(2):218-228
14. Guglielmi A, Ruzzenente A, Campagnaro T,  et al.  Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.  World J Surg. 2009;33(6):1247-1254
15. Jonas S, Thelen A, Benckert C,  et al.  Extended liver resection for intrahepatic cholangiocarcinoma: a comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification.  Ann Surg. 2009;249(2):303-309
16. Choi SB, Kim KS, Choi JY,  et al.  The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.  Ann Surg Oncol. 2009;16(11):3048-3056
17. Shirabe K, Mano Y, Taketomi A,  et al.  Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.  Ann Surg Oncol. 2010;17(7):1816-1822
18. Ercolani G, Vetrone G, Grazi GL,  et al.  Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival.  Ann Surg. 2010;252(1):107-114
19. Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.  Ann Surg Oncol. 2008;15(10):2787-2794
20. Endo I, Gonen M, Yopp AC,  et al.  Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.  Ann Surg. 2008;248(1):84-96
21. Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.  J Surg Oncol. 2007;96(2):160-165
22. Farges O, Fuks D, Boleslawski E,  et al.  Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group.  Ann Surg. 2011;254(5):824-829, discussion 830
23. Cho SY, Park SJ, Kim SH,  et al.  Survival analysis of intrahepatic cholangiocarcinoma after resection.  Ann Surg Oncol. 2010;17(7):1823-1830
24. Konstadoulakis MM, Roayaie S, Gomatos IP,  et al.  Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome.  Surgery. 2008;143(3):366-374
25. The Liver Cancer Study Group of Japan.  Intrahepatic cholangiocarcinoma . In: The Liver Cancer Study Group of Japan, eds. Classification of Primary Liver Cancer. 1st English ed. Tokyo, Japan: Kanehara; 1997:6-7
26. Edge SB, Byrd DR, Compton CC,  et al.  Intrahepatic bile ducts. In: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009:201-210
27. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.  Ann Surg. 2004;240(2):205-213
28. Little RJA, Rubin DB. Statistical Analysis With Missing Data. New York, NY: John Wiley & Sons; 1987
29. Ueno H, Mochizuki H, Hashiguchi Y,  et al.  Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection.  Ann Surg. 2007;245(1):80-87
30. de Jong MC, Nathan H, Sotiropoulos GC,  et al.  Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.  J Clin Oncol. 2011;29(23):3140-3145
31. Nuzzo G, Giuliante F, Ardito F,  et al.  Intrahepatic cholangiocarcinoma: prognostic factors after liver resection.  Updates Surg. 2010;62(1):11-19
32. Gruenberger B, Schueller J, Heubrandtner U,  et al.  Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.  Lancet Oncol. 2010;11(12):1142-1148
33. Valle J, Wasan H, Palmer DH,  et al; ABC-02 Trial Investigators.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.  N Engl J Med. 2010;362(14):1273-1281
34. Capussotti L, Massucco P, Ribero D, Viganò L, Muratore A, Calgaro M. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy.  Arch Surg. 2003;138(12):1316-1322
35. Pawlik TM, Scoggins CR, Zorzi D,  et al.  Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.  Ann Surg. 2005;241(5):715-722, discussion 722-724